Seth Karol, MD
Enriched profileAssociate Member, St. Jude Faculty · St. Jude Children's Research Hospital
Seth Karol is Associate Member, St. Jude Faculty at St. Jude Children's Research Hospital. OpenAlex indexes 172 publications with 2,582 citations (h-index 25); ClinicalTrials.gov lists 11 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 25 Oct 2026
Seth Karol, M.D., is Associate Member, St. Jude Faculty at St. Jude Children's Research Hospital. The public record shows 172 publications with 2,582 citations (h-index 25), centered on Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 4 companies, 1 NIH-funded awards (2020–2024).
- Most recent indexed publication: 2026 · Leukemia
- Top research focus: Acute Lymphoblastic Leukemia research
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 43 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 67.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Real World Asparaginase Therapy Toxicity
Sponsor: St. Jude Children's Research Hospital
- Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Sponsor: St. Jude Children's Research Hospital
Industry payments
Updated 25 Oct 2026
4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- JAZZ PHARMACEUTICALS INC.Program year20252 payments
- SERVIER PHARMACEUTICALS LLCProgram year20241 payment
NIH funding
Updated 25 Oct 2026
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia
St. Jude Children'S Research Hospital
FY2024$224,070K08CA250418 - Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia
St. Jude Children'S Research Hospital
FY2023$224,070K08CA250418 - Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia
St. Jude Children'S Research Hospital
FY2022$225,570K08CA250418
Congress activity
Updated 25 Oct 2026
30 congress contributions (2005–2026) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Abstract 2927: Synthetic lethality of G6PD deficiency and asparaginase for colorectal cancer therapy.
AACR Annual Meeting
AACR2026Co-author - Epigenetic and phenotypic signatures of T-cell response to blinatumomab in pediatric relapsed and refractory B-ALL.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 25 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.
Clinical cancer research
Article2026 - Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.
Clinical pharmacology and therapeutics
Guideline2025
Most-cited works
by citation count (OpenAlex)Network
Updated 25 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 25 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/seth-karol-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
stjude.org/care-treatment/patient-families/family-caregiver/caregivers-share-podcast/caregivers-share-season-3/what-is-a-clinical-trial.html
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stjude.org ↗ - Other
stjude.org/directory/k/seth-karol.html
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stjude.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
The Ohio State University (Columbus, Ohio)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stjude.org ↗ - BS
Duke University (Durham, North Carolina)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stjude.org ↗
Secondary affiliations
appointments beyond the home institution- Hematological Malignancies Program
St. Jude Children's Research Hospital
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stjude.org ↗ - Leukemia/Lymphoma Division
Department of Oncology, St. Jude Children's Research Hospital
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stjude.org ↗ - Assistant Member
Leukemia & Lymphoma Division, St. Jude Children's Research Hospital [past, per ORCID]
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗ - Research Associate
St. Jude Children's Research Hospital [past, per ORCID]
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗ - Physician Scientist Training Program Fellow
St. Jude Children's Research Hospital [past, per ORCID]
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Media & interviews
press, podcasts and appearances- Q&A with Seth Karol
MD: Risk factors for bone toxicity for patients with ALL (HCPLive)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas Merchant, DO
St. Jude Children's Research Hospital
Alberto Pappo, MD
St. Jude Children's Research Hospital
Stephen Gottschalk, MD
St. Jude Children's Research Hospital
Hiroto Inaba, MD
St. Jude Children's Research Hospital
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center